Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Notes underwriting agrmnt
|
|
EMMAUS LIFE SCIENCES, INC.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/08/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/03/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/24/2019 |
8-K
| Quarterly results |
| 03/11/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 01/07/2019 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among MYnd Analytics, Inc., Athena Merger Subsidiary, Inc. and Emmaus Life Sciences, Inc",
"Form of Emmaus Voting Agreement, including form of irrevocable proxy",
"Form of MYnd Voting Agreement, including form of irrevocable proxy",
"Form of Emmaus Lock-Up Agreement",
"Form of MYnd Lock-Up Agreement",
"CFO, Emmaus Life Sciences, Inc." |
|
| 12/20/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 10/15/2018 |
8-K
| Quarterly results |
| 10/05/2018 |
8-K/A
| Quarterly results |
| 09/28/2018 |
8-K
| Quarterly results |
| 09/17/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits|
Docs:
|
"Form of 10% Senior Secured Debenture",
"Form of Common Stock Purchase Warrant",
"Securities Purchase Agreement among Emmaus Life Sciences, Inc. and the Purchasers thereunder",
"Form of Security Agreement among Emmaus Life Sciences, Inc., Emmaus Medical, Inc., Newfield Nutrition Corporation and the holders of 10% Senior Secured Debentures",
"Form of Subsidiary Guarantee among Emmaus Medical, Inc., Newfield Nutrition Corporation and the holders of 10% Senior Secured Debentures",
"Fee Agreement made as of August 24, 2018 between Emmaus Life Sciences, Inc. and T.R. Winston & Company, LLC" |
|
| 07/19/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/18/2018 |
8-K
| Appointed a new director |
| 04/04/2018 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/07/2018 |
8-K
| Entry into a Material Definitive Agreement |
| 03/06/2018 |
8-K
| Termination of a Material Definitive Agreement, Financial Statements and Exhibits |
| 01/05/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/06/2017 |
8-K
| Quarterly results |
| 07/10/2017 |
8-K
| Form 8-K - Current report: |
| 06/16/2017 |
8-K
| Form 8-K - Current report |
| 06/05/2017 |
8-K
| Form 8-K - Current report |
| 05/19/2017 |
8-K
| Termination of a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/18/2017 |
8-K
| Form 8-K - Current report |
| 01/20/2017 |
8-K
| Form 8-K - Current report |
| 01/04/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/19/2016 |
8-K
| Form 8-K - Current report |
| 12/15/2016 |
8-K
| Form 8-K - Current report |
| 12/02/2016 |
8-K
| Form 8-K - Current report |
| 10/24/2016 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events |
| 10/07/2016 |
8-K
| Form 8-K - Current report |
| 09/30/2016 |
8-K/A
| Unregistered Sales of Equity Securities |
| 09/16/2016 |
8-K
| Entry into a Material Definitive Agreement |
| 09/13/2016 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/18/2016 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/06/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|